China Begins Testing an Antiviral Drug in Coronavirus Patients |

[bhaigan]

Patients in a clinical trial will receive a placebo or remdesivir, which has shown promise in laboratory studies.

 

China is forging ahead in the search for treatments for people sickened by the new coronavirus that has infected more than 28,000 people in a countrywide epidemic, killed more than 500 and seeded smaller outbreaks in 24 other nations.

The need is urgent: There are no approved treatments for illnesses caused by coronaviruses.

On Thursday, China began enrolling patients in a clinical trial of remdesivir, an antiviral medicine made by Gilead, the American pharmaceutical giant.

The drug has to be given intravenously, is experimental and not yet approved for any use, and has not been studied in patients with any coronavirus disease. But studies of infected mice and monkeys have suggested that remdesivir can fight coronaviruses.

And it appears to be safe. It was tested without ill effects in Ebola patients, although it did not work well against that virus, which is in a different family from coronaviruses.

 

Doctors in Washington State gave remdesivir to the first coronavirus patient in the United States last week after his condition worsened and pneumonia developed when he’d been in the hospital for a week. His symptoms improved the next day.

 

[bhaigan]

Good Improvements